Is Longeveron Inc. (LGVN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 14.0% / 30% | 186.4% / 30% | 0.8% / 30% | 22.95% / 5% | ✗ NOT HALAL |
| DJIM | 14.0% / 33% | 186.4% / 33% | 0.8% / 33% | 22.95% / 5% | ✗ NOT HALAL |
| MSCI | 5.7% / 33% | 75.2% / 33% | 0.3% / 33% | 22.95% / 5% | ✗ NOT HALAL |
| S&P | 14.0% / 33% | 186.4% / 33% | 0.8% / 33% | 22.95% / 5% | ✗ NOT HALAL |
| FTSE | 5.7% / 33% | 75.2% / 33% | 0.3% / 50% | 22.95% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 67.0% | |
| Operating Margin | -1479.2% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -164.7% | |
| Return on Assets (ROA) | -81.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$14M |
| Free Cash Flow | -$15M |
| Total Debt | $1M |
| Debt-to-Equity | 14.5 |
| Current Ratio | 1.3 |
| Total Assets | $26M |
Price & Trading
| Last Close | $0.97 |
| 50-Day MA | $0.66 |
| 200-Day MA | $0.85 |
| Avg Volume | 5.6M |
| Beta | 0.3 |
|
52-Week Range
$0.47
| |
About Longeveron Inc. (LGVN)
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Longeveron Inc. (LGVN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Longeveron Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Longeveron Inc.'s debt ratio?
Longeveron Inc.'s debt ratio is 14.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 5.7%.
What are Longeveron Inc.'s key financial metrics?
Longeveron Inc. has a market capitalization of $27M, and revenue of $2M. Return on equity stands at -164.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.